Stroke Care In UK Severely Deficient
September 2007 - An editorial in the British Medical Journal (BMJ) recently argued that the
UK urgently needs to reorganize stroke services to improve patient outcomes. Professor Hugh Markus from St George's
University Hospital, London drew attention to a number of studies placing the UK at the bottom of western European
league tables and considered the reasons for this variation in results.
The author suggested that differences in the care process are significant with many European countries
integrating stroke treatment into neurology services. Until recently, the UK tended to treat it as a "Cinderella"
diagnosis dealt with inconsistently by neurology, general or geriatric medicine. He commented that while it would be
easy to conclude this has resulted in underinvestment, in reality the cost of stroke care appears to be at least as
high as in countries with better outcomes.
Professor Markus identified organizational and structural problems including lack of focus on acute
stroke care which has assumed even greater importance with the development of specific treatments such as thrombolysis
(administration of anti-clotting drugs within three hours). Effective thrombolytic services exist in many countries in
Europe, North America, and Australia, where as many as 20-30 per cent of eligible patients receive therapy compared to
less than 1 per cent in the UK.
A 2005 National Audit Office report acknowledged these deficiencies concluding that improvements to
care organization in England could save £20million annually with 550 deaths avoided and 1700 patients fully
recovered who would not otherwise do so. The Department of Health National Stroke Strategy is due to publish its
response and recommendations in autumn 2007.
Hugh Markus argued that the perception of stroke among health professionals and the public must be
changed so that it is viewed as a condition requiring emergency treatment. He stressed that the UK also has a severe
shortage of trained stroke specialists. Research shows that prompt brain scanning is the most cost effective
diagnostic and treatment strategy. While many European countries perform a scan on admission, many UK units "struggle
to provide it within 24 hours".
He concluded that improvements to early diagnosis with imaging, patient monitoring and treatment of
physiological parameters will have a positive impact on outcomes independent of thrombolytic therapy. Professor Markus
argued that if acute systems were effective, implementation of other new treatments would be facilitated.
Related Articles
-
American adults have a higher prevalence of stroke than Europeans, due in part to a higher rate of risk
factors and barriers to health care in the United States.
-
Longstanding anxiety significantly
increases the risk of heart attack in men, even when other common risk factors are taken into account.
-
Two recent studies have thrown new light on links between cardiovascular and
brain health.